The prognostic significance of leukocytosis in cervical cancer

International Journal of Gynecological Cancer

Volumn 17, Issue 2, 2007, Pages 465-470

  Garcia Arias, A ^a   Cetina, L ^a   Candelaria, M ^a   Robles, E ^a   Duenas Gonzalez A ^a,b  

^a INSTITUTO NACIONAL DE CANCEROLOGÍA   (Mexico)

^b UNAM ^*  (Mexico)

Author keywords

Cervical cancer; Chemoradiation; Leukocytosis

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS; UTERINE CERVIX CANCER;

ADULT; AGED; CARCINOMA; COHORT STUDIES; FEMALE; HUMANS; LEUKOCYTOSIS; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SYNDROME; UTERINE CERVICAL NEOPLASMS;

EID: 33947246972     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2007.00816.x     Document Type: Article

References (42)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005:55:74-108.
2. Duenas-Gonzalez A, Cetina L, Mariscal I, de la Garza J. Modern management of locally advanced cervical carcinoma. Cancer Treat Rev 2003;29:389-99.
3. Candelaria M, Garcia-Arias A, Cetina L, Duenas-Gonzalez A. Radiosensitizers in cervical cancer. Cisplatin and beyond. Radiat Oncol 2006;1:15.
4. Pedersen D, Sogaard H, Overgaard J, Bentzen SM. Prognostic value of pretreatment factors in patients with locally advanced carcinoma of the uterine cervix treated by radiotherapy alone. Acta Oncol 1995;34:787-95.
5. Yalman D, Aras AB, Ozkok S et al. Prognostic factors in definitive radiotherapy of uterine cervical cancer. Eur J Gynaecol Oncol 2003;24:309-14.
6. Yamashita H, Nakagawa K, Tago M, Shiraishi K, Nakamura N, Ohtomo K. Treatment results and prognostic analysis of radical radiotherapy for locally advanced cancer of the uterine cervix. Br J Radiol 2005;78:821-6.
7. Kersemaekers AM, Kenter GG, Hermans J, Fleuren GJ, van de Vijver MJ. Allelic loss and prognosis in carcinoma of the uterine cervix. Int J Cancer 1998;79:411-7.
8. Kersemaekers AM, van de Vijver MJ, Kenter GG, Fleuren GJ. Genetic alterations during the progression of squamous cell carcinomas of the uterine cervix. Genes Chromosomes Cancer 1999;26:346-54.
9. Duenas-Gonzalez A, Lizano M, Candelaria M, Cetina L, Arce C, Cervera E. Epigenetics of cervical cancer. An overview and therapeutic perspectives. Mol Cancer 2005;4:38.
10. Brennan JT. Oncologic emergencies and paraneoplastic syndromes. Prim Care 1987;14:365-79.
11. Agarwala SS. Paraneoplastic syndromes. Med Clin North Am 1996;80:173-84.
12. Staszewski H. Hematological paraneoplastic syndromes. Semin Oncol 1997;24:329-33.
13. Ascensao JL, Oken MM, Ewing SL, Goldberg RJ, Kaplan ME. Leukocytosis and large cell lung cancer. A frequent association. Cancer 1987;60:903-5.
14. Ward PC. The myeloid leukocytoses. Postgrad Med 1980;67:219-29.
15. Shoenfeld Y, Tal A, Berliner S, Pinkhas J. Leukocytosis in non hematological malignancies - a possible tumor associated marker. J Cancer Res Clin Oncol 1986;111:54-8.
16. Hiraki A, Ueoka H, Takata I, Gemba K, Bessho A. Hypercalcemia- leukocytosis syndrome associated with lung cancer. Lung Cancer 2004;43:301-7.
17. Yoneda T, Aufdemorte T, Nishimura R, Nishikawa N, Sakuda M. Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes. J Clin Oncol 1991;9:468-77.
18. Yoneda T, Nishimura R, Kato I, Ohmae M, Takita M. Frequency of the hypercalcemia-leukocytosis syndrome in oral malignancies. Cancer 1991;68:617-22.
19. Kato N, Yasukawa K, Onozuka T, Kimura K. Paraneoplastic syndromes of leukocytosis, thrombocytosis and hypercalcemia associated with squamous cell carcinoma. J Dermatol 1999;26:352-8.
20. Taillan B, Vinti H, Viens P, Fuzibet JG, Dujardin P. Hypercalcemia associated with hyperleukocytosis in epidermoid carcinoma of the cervix uteri. Presse Med 1988;17:1704-5.
21. Ahn HJ, Park YH, Chang YH, Park SH, Kim MS. A case of uterine cervical cancer presenting with granulocytosis. Korean J Intern Med 2005;20:247-50.
22. Kyo S, Kanaya T, Takakura M, Inoue M. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and Il-6. Gynecol Oncol 2000;8:383-7.
23. Watanabe A, Wachi T, Omi H et al. Granulocyte colony-stimulating factor-producing small-cell carcinoma of the uterine cervix: report of a case. Diagn Cytopathol 2000;23:269-74.
24. Nasu K, Inoue C, Takai N, Kashima K, Miyakawa I. Squamous cell carcinoma of the cervix producing granulocyte colony-stimulating factor. Obstet Gynecol 2004;104:1086-8.
25. Connor JP. Aggressive carcinosarcoma of the uterine cervix associated with high levels of granulocyte colony stimulating factor: case report and laboratory correlates. Gynecol Oncol 2006;103:349-53.
26. Cetina L, Rivera L, Hinojosa J, Poitevin A, Uribe J. Routine management of locally advanced cervical cancer with concurrent radiation and cisplatin. Five-year results. BMC Women's Health 2006;7:3.
27. McKee LC Jr. Excess leukocytosis (leukemoid reactions) associated with malignant diseases. South Med J 1985;78:1475-82.
28. Kitamura H, Kodama F, Odagiri S, Nagahara N, Inoue T, Kanisawa M. Granulocytosis associated with malignant neoplasms: a clinicopathologic study and demonstration of colony-stimulating activity in tumor extracts. Hum Pathol 1989;20:878-85.
29. Sato K. A paraneoplastic syndrome of hypercalcemia and leukocytosis associated with solid tumors: production of interleukin 1 alpha (IL-1 alpha) and granulocyte colony-stimulating factor (G-CSF) by clonal squamous cell carcinoma cells. Nippon Naibunpi Gakkai Zasshi 1988;64:1223-7.
30. Yoneda T, Alsina MA, Chavez JB, Bonewald L, Nishimura R, Mundy GR. Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice. J Clin Invest 1991;7:977-85.
31. Black K, Garrett IR, Mundy GR. Chinese hamster ovarian cells transfected with the murine interleukin-6 gene cause hypercalcemia as well as cachexia, leukocytosis and thrombocytosis in tumor-bearing nude mice. Endocrinology 1991;28:2657-9.
32. Kojima K, Nakashima F, Boku A, Muroishi Y, Nakanishi I, Oda Y. Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis. Histol Histopathol 2002;17:1005-16.
33. Kasuga I, Makino S, Kiyokawa H, Katoh H, Ebihara Y, Ohyashiki K. Tumor-related leukocytosis is linked with poor prognosis in patients with lung carcinoma. Cancer 2001;92:2399-405.
34. Nakamura K, Takahashi T, Tsuyuoka R et al. Identification of colony-stimulating factor activity in patients with malignant tumors associated with excessive leukocytosis. Jpn J Clin Oncol 1991;21:395-9.
35. Tachibana M, Murai MG. CSF production in human bladder cancer and its ability to promote autocrine growth. Cytokines Cell Mol Ther 1998;4:113-20.
36. Harada R, Uemura Y, Kobayashi M et al. Establishment and characterization of a new lung cancer cell line (MI-4) producing high levels of granulocyte colony stimulating factor. Jpn J Cancer Res 2002;93:667-76.
37. Iglesias M, Plowman GD, Woodworth CD. Interleukin-6 and interleukin-6 soluble receptor regulate proliferation of normal, human papillomavirus- immortalized, and carcinoma-derived cervical cells in vitro. Am J Pathol 1995;146:944-52.
38. Wei LH, Kuo ML, Chen CA et al. Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene 2003;22:1517-27.
39. Mueller MM, Herold-Mende CC, Riede D, Lange M, Steiner HH, Fusenig NE. Autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor in human gliomas with tumor progression. Am J Pathol 1999;155:1557-67.
40. Tsuyuoka R, Takahashi T, Sasaki Y et al. Colony-stimulating factor-producing tumours: production of granulocyte colony-stimulating factor and interleukin-6 is secondary to interleukin-1 production. Eur J Cancer 1994;30:2130-6.
41. Peluffo GD, Stillitani I, Rodriguez VA, Diament MJ, Klein SM. Reduction of tumor progression and paraneoplastic syndrome development in murine lung adenocarcinoma by nonsteroidal anti-inflammatory drugs. Int J Cancer 2004;10:825-30.
42. Diament MJ, Peluffo GD, Stillitani I et al. Inhibition of tumor progression and paraneoplastic syndrome development in a murine lung adenocarcinoma by medroxyprogesterone acetate and indomethacin. Cancer Invest 2006;24:126-31.